A total of 111 patients received at least one dose of the study medicines. The table
below shows the gender and age of these patients.
Patients who received at least one dose of the study medicines
Low-dose triple Low-dose to high-dose High-dose triple
therapy group triple therapy group therapy group
47 patients 9 patients 55 patients
Female 23 (49%) 5 (56%) 36 (65%)
Male 24 (51%) 4 (44%) 19 (35%)
Age range
20 to 74 41 to 66 26 to 78
(years)
Average age
48 48 54
(years)
For more detailed information about the patients included in this study, see the
scientific results summary (a link to the summary is provided at the end of this
document).